BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15155195)

  • 1. Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.
    Cheshenko N; Keller MJ; MasCasullo V; Jarvis GA; Cheng H; John M; Li JH; Hogarty K; Anderson RA; Waller DP; Zaneveld LJ; Profy AT; Klotman ME; Herold BC
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2025-36. PubMed ID: 15155195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
    Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
    Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.
    Scordi-Bello IA; Mosoian A; He C; Chen Y; Cheng Y; Jarvis GA; Keller MJ; Hogarty K; Waller DP; Profy AT; Herold BC; Klotman ME
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3607-15. PubMed ID: 16127029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
    Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
    Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.
    Rusnati M; Vicenzi E; Donalisio M; Oreste P; Landolfo S; Lembo D
    Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections.
    Madan RP; Mesquita PM; Cheshenko N; Jing B; Shende V; Guzman E; Heald T; Keller MJ; Regen SL; Shattock RJ; Herold BC
    J Virol; 2007 Jul; 81(14):7636-46. PubMed ID: 17494078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.
    Hayashi K; Onoue H; Sasaki K; Lee JB; Kumar PK; Gopinath SC; Maitani Y; Kai T; Hayashi T
    Arch Virol; 2014 Mar; 159(3):425-35. PubMed ID: 24046087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seminal plasma reduces the effectiveness of topical polyanionic microbicides.
    Patel S; Hazrati E; Cheshenko N; Galen B; Yang H; Guzman E; Wang R; Herold BC; Keller MJ
    J Infect Dis; 2007 Nov; 196(9):1394-402. PubMed ID: 17922405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bowman‒Birk Inhibitor Suppresses Herpes Simplex Virus Type 2 Infection of Human Cervical Epithelial Cells.
    Liu Y; Xu XQ; Zhang B; Gu J; Meng FZ; Liu H; Zhou L; Wang X; Hou W; Ho WZ
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30322047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection.
    Bourne N; Stanberry LR; Kern ER; Holan G; Matthews B; Bernstein DI
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2471-4. PubMed ID: 10952597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus.
    Keller MJ; Klotman ME; Herold BC
    Am J Reprod Immunol; 2003 May; 49(5):279-84. PubMed ID: 12854732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical microbicides for the prevention of genital herpes infection.
    Keller MJ; Tuyama A; Carlucci MJ; Herold BC
    J Antimicrob Chemother; 2005 Apr; 55(4):420-3. PubMed ID: 15743896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrageenan is a potent inhibitor of papillomavirus infection.
    Buck CB; Thompson CD; Roberts JN; Müller M; Lowy DR; Schiller JT
    PLoS Pathog; 2006 Jul; 2(7):e69. PubMed ID: 16839203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
    Isaacs CE; Wen GY; Xu W; Jia JH; Rohan L; Corbo C; Di Maggio V; Jenkins EC; Hillier S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):962-70. PubMed ID: 18195068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP; Keller MJ; Herold BC
    Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.
    Antoine TE; Mishra YK; Trigilio J; Tiwari V; Adelung R; Shukla D
    Antiviral Res; 2012 Dec; 96(3):363-75. PubMed ID: 23047013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.
    Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A
    J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.
    Antoine TE; Shukla D
    Antivir Ther; 2014; 19(1):15-29. PubMed ID: 23813409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC
    J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.